Back to Search
RUSSELL DEVORE, MD
MD
Hematology & Oncology Physician
NPI: 1952301459Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35731(KY)MD0000018111(TN)
Research & Publications (19)
Implementation of low-fat, low-sugar, and portion-controlled nutrition guidelines in competitive food venues of Maine public high schools.
PMID 18076414·J Sch Health·2007
8-other
Wavelet compression of three-dimensional time-lapse biological image data.
PMID 15683567·Microsc Microanal·2005
7-preclinical
The vending and à la carte policy intervention in Maine public high schools.
PMID 16263047·Prev Chronic Dis·2005
8-other
Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.
PMID 15277257·Ann Oncol·2004
3-trial
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.
PMID 15169807·J Clin Oncol·2004
3-trial
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597.
PMID 12697880·J Clin Oncol·2003
3-trial
Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.
PMID 11714542·Lung Cancer·2001
3-trial
Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer.
PMID 11565675·Ann Thorac Surg·2001
8-other
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group.
PMID 11304763·J Clin Oncol·2001
3-trial
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy.
PMID 11291837·Invest New Drugs·2001
3-trial
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
PMID 11205920·Clin Cancer Res·2001
3-trial
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
PMID 10623703·J Clin Oncol·2000
3-trial
Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.
PMID 10981290·Oncology (Williston Park)·2000
6-review
A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial.
PMID 14725740·Clin Lung Cancer·2000
8-other
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
PMID 10863062·Int J Radiat Oncol Biol Phys·2000
3-trial
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
PMID 10856094·J Clin Oncol·2000
3-trial
Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.
PMID 10694563·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9700 TUNBRIDGE LN
KNOXVILLE, TN 37922 - Phone
- (655) 989-5543
Quick Facts
- NPI
- 1952301459
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile